These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 7707539)
1. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. Robertson ES; Grossman S; Johannsen E; Miller C; Lin J; Tomkinson B; Kieff E J Virol; 1995 May; 69(5):3108-16. PubMed ID: 7707539 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses. Zhao B; Dalbiès-Tran R; Jiang H; Ruf IK; Sample JT; Wang F; Sample CE J Virol; 2003 May; 77(10):5639-48. PubMed ID: 12719556 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. Marshall D; Sample C J Virol; 1995 Jun; 69(6):3624-30. PubMed ID: 7745710 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. Johannsen E; Koh E; Mosialos G; Tong X; Kieff E; Grossman SR J Virol; 1995 Jan; 69(1):253-62. PubMed ID: 7983717 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2. Lin J; Johannsen E; Robertson E; Kieff E J Virol; 2002 Jan; 76(1):232-42. PubMed ID: 11739688 [TBL] [Abstract][Full Text] [Related]
6. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site. Zhao B; Sample CE J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless. Zimber-Strobl U; Strobl LJ; Meitinger C; Hinrichs R; Sakai T; Furukawa T; Honjo T; Bornkamm GW EMBO J; 1994 Oct; 13(20):4973-82. PubMed ID: 7957063 [TBL] [Abstract][Full Text] [Related]
8. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters. Sjöblom A; Nerstedt A; Jansson A; Rymo L J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374 [TBL] [Abstract][Full Text] [Related]
9. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus. Jiang H; Cho YG; Wang F J Virol; 2000 Jul; 74(13):5921-32. PubMed ID: 10846073 [TBL] [Abstract][Full Text] [Related]
10. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation. Harada S; Yalamanchili R; Kieff E J Virol; 1998 Dec; 72(12):9948-54. PubMed ID: 9811732 [TBL] [Abstract][Full Text] [Related]
11. A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa. Zhao B; Marshall DR; Sample CE J Virol; 1996 Jul; 70(7):4228-36. PubMed ID: 8676443 [TBL] [Abstract][Full Text] [Related]
13. EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes. Johannsen E; Miller CL; Grossman SR; Kieff E J Virol; 1996 Jun; 70(6):4179-83. PubMed ID: 8648764 [TBL] [Abstract][Full Text] [Related]
14. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421 [TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA. Waltzer L; Perricaudet M; Sergeant A; Manet E J Virol; 1996 Sep; 70(9):5909-15. PubMed ID: 8709211 [TBL] [Abstract][Full Text] [Related]
16. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter. Sjöblom A; Jansson A; Yang W; Laín S; Nilsson T; Rymo L J Gen Virol; 1995 Nov; 76 ( Pt 11)():2679-92. PubMed ID: 7595375 [TBL] [Abstract][Full Text] [Related]
17. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Grossman SR; Johannsen E; Tong X; Yalamanchili R; Kieff E Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7568-72. PubMed ID: 8052621 [TBL] [Abstract][Full Text] [Related]
18. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines. Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616 [TBL] [Abstract][Full Text] [Related]
19. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines. Chen A; Zhao B; Kieff E; Aster JC; Wang F J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691 [TBL] [Abstract][Full Text] [Related]
20. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins. Sample C; Parker B Virology; 1994 Dec; 205(2):534-9. PubMed ID: 7975254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]